Press Release : Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research

— The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science. — This is the first time that research scientists can conduct oncology research with Foundation Medicine’s comprehensive genomic profiling in their own laboratories to gain meaningful genomic insights and deepen their understanding of cancer biology.

Read the source article at Stock Market Quotes and News
2021-10-25 06:00:03